NO995549L - Anvendelse av 5-(4-(2-(M-metyl-N-(2-pyridyl)amino)-etoksy)bensyl)2,4-tiazolidindion ved behandling av polycystisk ovairiesyndrom og gestationell diabetes - Google Patents
Anvendelse av 5-(4-(2-(M-metyl-N-(2-pyridyl)amino)-etoksy)bensyl)2,4-tiazolidindion ved behandling av polycystisk ovairiesyndrom og gestationell diabetesInfo
- Publication number
- NO995549L NO995549L NO995549A NO995549A NO995549L NO 995549 L NO995549 L NO 995549L NO 995549 A NO995549 A NO 995549A NO 995549 A NO995549 A NO 995549A NO 995549 L NO995549 L NO 995549L
- Authority
- NO
- Norway
- Prior art keywords
- thiazolidinedione
- pyridyl
- ethoxy
- benzyl
- amino
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Emergency Medicine (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
Nye metoder for anvendelse av tiazolidinonderivater og beslektede antihy- perglykemiske midler for å behandle populasjoner med risiko for utvikling av ikke- insulinavhengig diabetes mellitus (NIDDM) og komplikasjoner som stammer der- fra, er beskrevet, l en utførelsesform blir forbindelsene ifølge foreliggende oppfin- nelse anvendt for å behandle polycystisk ovariesyndrom for å forhindre eller ut- sette opptreden av ikke-insulinavhengig diabetes mellitus. Ved en annen utførel- sesform blir forbindelsene ifølge foreliggende oppfinnelse anvendt for å behandle svangerskapsdiabetes for å forhindre eller utsette opptreden av ikke-insulin- avhengig diabetes mellitus.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08/856,987 US5874454A (en) | 1993-09-15 | 1997-05-15 | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
PCT/US1998/010113 WO1998051305A1 (en) | 1997-05-15 | 1998-05-14 | Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)-ethoxy)benzyl)2,4-thiazolidinedione in the treatment of polycystic ovary syndrome and gestational diabetes |
Publications (2)
Publication Number | Publication Date |
---|---|
NO995549L true NO995549L (no) | 1999-11-12 |
NO995549D0 NO995549D0 (no) | 1999-11-12 |
Family
ID=25324901
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO995549A NO995549D0 (no) | 1997-05-15 | 1999-11-12 | Anvendelse av 5-(4-(2-(M-metyl-N-(2-pyridyl)amino)-etoksy)bensyl)2,4-tiazolidindion ved behandling av polycystisk ovairiesyndrom og gestationell diabetes |
Country Status (14)
Country | Link |
---|---|
US (1) | US5874454A (no) |
EP (1) | EP0981346A1 (no) |
JP (1) | JP2001525827A (no) |
KR (1) | KR20010012556A (no) |
AU (1) | AU731690B2 (no) |
BR (1) | BR9809120A (no) |
CA (1) | CA2282473A1 (no) |
HU (1) | HUP0003397A3 (no) |
IL (1) | IL132125A0 (no) |
IS (1) | IS5177A (no) |
NO (1) | NO995549D0 (no) |
PL (1) | PL336764A1 (no) |
WO (1) | WO1998051305A1 (no) |
ZA (1) | ZA984084B (no) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6046222A (en) * | 1993-09-15 | 2000-04-04 | Warner-Lambert Company | Use of thiazolidinedione derivatives in the treatment of polycystic ovary syndrome, gestational diabetes and disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
JP2001072592A (ja) | 1999-07-01 | 2001-03-21 | Kyowa Hakko Kogyo Co Ltd | テロメラーゼ阻害剤 |
GB0019223D0 (en) * | 2000-08-04 | 2000-09-27 | Smithkline Beecham Plc | Novel pharmaceutical |
GB0021865D0 (en) * | 2000-09-06 | 2000-10-18 | Smithkline Beecham Plc | Novel pharmaceutical |
US6452014B1 (en) | 2000-12-22 | 2002-09-17 | Geron Corporation | Telomerase inhibitors and methods of their use |
CN104163864B (zh) | 2007-03-30 | 2017-08-01 | Ambrx公司 | 经修饰fgf‑21多肽和其用途 |
US9339458B2 (en) * | 2009-02-18 | 2016-05-17 | Itf Research Pharma, S.L.U. | Use of vaginal insulin sensitizing agents |
ES2344183B1 (es) * | 2009-02-18 | 2011-06-10 | Italfarmaco, S.A. | Uso de agentes sensibilizantes a insulina por via vaginal. |
KR20240024362A (ko) | 2014-10-24 | 2024-02-23 | 브리스톨-마이어스 스큅 컴퍼니 | 변형된 fgf-21 폴리펩티드 및 그의 용도 |
RU2665969C1 (ru) * | 2017-05-04 | 2018-09-05 | Федеральное государственное бюджетное образовательное учреждение дополнительного профессионального образования "Российская медицинская академия непрерывного профессионального образования" Министерства здравоохранения Российской Федерации (ФГБОУ ДПО РМАНПО Минздрава России) | Способ лечения синдрома поликистозных яичников |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5522636A (en) * | 1978-08-04 | 1980-02-18 | Takeda Chem Ind Ltd | Thiazoliding derivative |
JPS6051189A (ja) * | 1983-08-30 | 1985-03-22 | Sankyo Co Ltd | チアゾリジン誘導体およびその製造法 |
AR240698A1 (es) * | 1985-01-19 | 1990-09-28 | Takeda Chemical Industries Ltd | Procedimiento para preparar compuestos de 5-(4-(2-(5-etil-2-piridil)-etoxi)benzil)-2,4-tiazolidindiona y sus sales |
US4873255A (en) * | 1987-02-04 | 1989-10-10 | Sankyo Company Limited | Thiazolidinone derivatives, their preparation and their use |
EP0306228B1 (en) * | 1987-09-04 | 1999-11-17 | Beecham Group Plc | Substituted thiazolidinedione derivatives |
MX15171A (es) * | 1988-03-08 | 1993-05-01 | Pfizer | Derivados de tiazolidinodiona hipoglicemicos |
US5223522A (en) * | 1988-03-08 | 1993-06-29 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
US5120754A (en) * | 1988-03-08 | 1992-06-09 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
WO1989008650A1 (en) * | 1988-03-08 | 1989-09-21 | Pfizer Inc. | Thiazolidinedione hypoglycemic agents |
US4897405A (en) * | 1989-04-21 | 1990-01-30 | American Home Products Corporation | Novel naphthalenylalkyl-3H-1,2,3,5-oxathiadiazole 2-oxides useful as antihyperglycemic agents |
GB8919417D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
GB8919434D0 (en) * | 1989-08-25 | 1989-10-11 | Beecham Group Plc | Novel compounds |
CA2071629C (en) * | 1990-02-09 | 1997-12-30 | Jerry R. Colca | Use of insulin sensitizing agents to treat hypertension |
GB9023585D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
GB9023583D0 (en) * | 1990-10-30 | 1990-12-12 | Beecham Group Plc | Novel compounds |
DE69213738T2 (de) * | 1991-06-25 | 1997-01-30 | Pfizer | Thiazolidindione als hypoglykämische wirkstoffe |
EP0719140B1 (en) * | 1993-09-15 | 2007-10-31 | Daiichi Sankyo Company, Limited | Use of thiazolidinediones to prevent or delay onset of niddm |
US5457109A (en) * | 1993-09-15 | 1995-10-10 | Warner-Lambert Company | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus |
-
1997
- 1997-05-15 US US08/856,987 patent/US5874454A/en not_active Expired - Fee Related
-
1998
- 1998-05-14 AU AU74949/98A patent/AU731690B2/en not_active Ceased
- 1998-05-14 BR BR9809120-4A patent/BR9809120A/pt not_active IP Right Cessation
- 1998-05-14 WO PCT/US1998/010113 patent/WO1998051305A1/en not_active Application Discontinuation
- 1998-05-14 ZA ZA984084A patent/ZA984084B/xx unknown
- 1998-05-14 HU HU0003397A patent/HUP0003397A3/hu unknown
- 1998-05-14 JP JP54965498A patent/JP2001525827A/ja active Pending
- 1998-05-14 KR KR1019997010511A patent/KR20010012556A/ko not_active Application Discontinuation
- 1998-05-14 PL PL98336764A patent/PL336764A1/xx unknown
- 1998-05-14 IL IL13212598A patent/IL132125A0/xx unknown
- 1998-05-14 CA CA002282473A patent/CA2282473A1/en not_active Abandoned
- 1998-05-14 EP EP98922391A patent/EP0981346A1/en not_active Withdrawn
-
1999
- 1999-09-10 IS IS5177A patent/IS5177A/is unknown
- 1999-11-12 NO NO995549A patent/NO995549D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
PL336764A1 (en) | 2000-07-17 |
KR20010012556A (ko) | 2001-02-15 |
EP0981346A1 (en) | 2000-03-01 |
JP2001525827A (ja) | 2001-12-11 |
CA2282473A1 (en) | 1998-11-19 |
ZA984084B (en) | 1998-11-20 |
AU731690B2 (en) | 2001-04-05 |
HUP0003397A2 (hu) | 2002-01-28 |
IL132125A0 (en) | 2001-03-19 |
US5874454A (en) | 1999-02-23 |
WO1998051305A1 (en) | 1998-11-19 |
AU7494998A (en) | 1998-12-08 |
HUP0003397A3 (en) | 2002-02-28 |
NO995549D0 (no) | 1999-11-12 |
IS5177A (is) | 1999-09-10 |
BR9809120A (pt) | 2000-08-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO995932L (no) | Anvendelse av tiazolidindion-derivater i behandling av polycystiske ovariesyndrom og svangerskapsdiabetes | |
WO1995007697A3 (en) | Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus | |
NO995549L (no) | Anvendelse av 5-(4-(2-(M-metyl-N-(2-pyridyl)amino)-etoksy)bensyl)2,4-tiazolidindion ved behandling av polycystisk ovairiesyndrom og gestationell diabetes | |
NZ501260A (en) | Treatment of diabetes with thiazolidinedione and metformin | |
NO20002963D0 (no) | Anvendelse av forbindelsen 5-[4-[2-(5-etylpyridin-2-yl)- etoksy]benzyl]tiazolidin-2,4-dion (pioglitazone) for fremstilling av et medikament for behandling av svekket glukosetoleranse | |
EA200601145A1 (ru) | Таблетка замедленного высвобождения сенсибилизатора к инсулину и других антидиабетических агентов | |
AR057970A2 (es) | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus y condiciones asociadas con la diabetes mellitus y procedimientos para preprar dichas composiciones | |
NZ504703A (en) | Substituted thiazolidinedione derivative, process for its preparation and its pharmaceutical use | |
AR016660A1 (es) | Procedimiento para preparar 5-{4-[2-(n-metil-n(2-piridil)amino)etoxi]bencil} -2,4-tiazolidindiona, o una de sus formas tautomericas o de sus sales | |
AP1562A (en) | Thiazolidinedione derivatives and its use as antidiabetic. | |
CY1105354T1 (el) | Ένα παραγωγο θειαζολιδινοδιονης και η χρηση του σαν αντι-διαβητικο | |
DK1349855T3 (da) | 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl)thiazolidin-2,4-dionmesylatsalt | |
WO2000063206A3 (en) | Thiazolidinedione derivative and its use as antidiabetic | |
CO4940422A1 (es) | Novedoso metodo de tratamiento | |
UY25048A1 (es) | Composiciones para el tratamiento de la diabetes mellitus | |
DK1315721T3 (da) | Et Thiazolidindionderivat og dets anvendelse som et antidiabetisk middel | |
DK1446404T3 (da) | Rosiglitazonedisylater og deres anvendelse som antidiabetika | |
AP2002002673A0 (en) | Thiazolidinedione salt for the treatment of diabetes mellitus. | |
AP1785A (en) | Tartrate salt of thiazolidinedione derivative. | |
HUP0301799A3 (en) | Use of 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyl)thiazolidine-2,4-dione hydriodide for treating diabetes mellitus, process for preparation thereof and pharmaceutical composition containing the same | |
HK1068884A1 (en) | 5-(4-(2-(n-methyl-n-(2-pyridyl)amino)ethoxy)benzyleof; and its use as pharmaceutical active ingredie)thiazolidine-2,4-dione benzenesulfonate; process for its preparation; polymorphs i, ii and iii thernt | |
NZ524933A (en) | Sodium salts of 5-[4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione and pharmaceutical composition thereof | |
ECSP003435A (es) | Nuevos compuestos | |
ECSP003434A (es) | Nuevos compuestos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |